ANTI-ENOS Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Recommended dilutions
Western Blot 1:500 - 1:1000

Optimal dilutions should be determined by the user.

Biochem/physiol Actions

Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.

ANTI-ENOS Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-ENOS Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Merck KGaA	--	ordercn@merckgroup.com	China	6394	58

---

• Monoclonal Anti-NANOS3 antibody produced in mouse
• Anti-NOS3 (Ab-495) antibody produced in rabbit
• Anti-NOS3 (Ab-1177) antibody produced in rabbit
• Anti-ECNOS antibody produced in rabbit
• Anti-eNOS antibody produced in rabbit
• Anti-nitric oxide synthase 3 (endothelial cell) antibody produced in rabbit
• Anti-phospho-NOS3 (pSer1177) antibody produced in rabbit
• ANTI-ENDOTHELIAL NITRIC OXIDE SYNTHASE
• ANTI-ENDOTHELIAL NOS
• ANTI-ENOS
• ANTI-ENOS, N-TERMINAL, HUMAN ENDOTHELIAL CELL
• ANTI-ENOS TYPE III
• ANTI-HUMAN ENOS
• ANTI-HUMAN NOS III
• ANTI-HUMAN NITRIC OXIDE SYNTHASE III
• ANTI-NITRIC OXIDE SYNTHASE (ENDOTHELIAL)
• ANTI-NITRIC-OXIDE SYNTHASE (2-12), ENDOTHELIAL N-TERMINAL RABBIT PAB
• ANTI-NITRIC OXIDE SYNTHASE-3
• ANTI-NOS-3
• ANTI-NOS TYPE III
• ANTI-ECNOS
• ANTI-ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE, TYPE III
• ANTI-ENOS (2-12), ENDOTHELIAL N-TERMINAL RABBIT PAB
• ANTI-ENOS/NOS TYPE III
• ANTI-HUMAN ENOS AA 1030 - 1203
• ANTI-HUMAN ENITRIC OXIDE SYNTHASE AA 1030 - 1203
• ANTI-NITRIC OXIDE SYNTHASE, N-TERMINAL, HUMAN ENDOTHELIAL CELL
• ANTI-NITRIC OXIDE SYNTHASE, N-TERMINAL, HUMAN ENDOTHELIAL CELL (RABBIT)
• ANTI-NOS III
• ANTI-NOS (ENDOTHELIAL)
• Anti-MGC120114
• Anti-NANOS1L